Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

MDM2

Other MDM2 amplified sarcomas: The value of MDM2 inhibitors

Date

14 Mar 2024

Session

MDM2

Topics

Tumour Site

Sarcoma

Presenters

Hans Gelderblom

Authors

H. Gelderblom

Author affiliations

  • Medical Oncology Dept, LUMC - Leids Universitair Medisch Centrum, 2300 RC - Leiden/NL

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.